Evidence map›Paper›PMID 40918091›Full record

ArticleFrontiers in immunology2025

Correction: RG100204, a novel Aquaporin-9 inhibitor, reduces septic cardiomyopathy and multiple organ failure in murine sepsis.

Shireen Mohammad, Caroline E O'Riordan, Chiara Verra, Eleonora Aimaretti, Gustavo Ferreira Alves, Klaus Dreisch, Johan Evenäs, Patrizia Gena, Angela Tesse, Michael Rützler and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Shireen MohammadWilliam Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Caroline E O'RiordanWilliam Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Chiara VerraWilliam Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Eleonora AimarettiDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Gustavo Ferreira AlvesDepartment of Neurosciences "Rita Levi Montalcini", University of Turin, Turin, Italy.
Klaus DreischRed Glead Discovery Akiebolag (AB), Lund, Sweden.
Johan EvenäsRed Glead Discovery Akiebolag (AB), Lund, Sweden.
Patrizia GenaDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Bari, Italy.
Angela TesseNantes Université, Instite National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Rescherche Scientifique (CNRS), l'institut du Thorax, Nantes, France.
Michael RützlerDepartment of Biochemistry and Structural Biology, Lund University, Lund, Sweden.
Massimo CollinoDepartment of Neurosciences "Rita Levi Montalcini", University of Turin, Turin, Italy.
Giuseppe CalamitaDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Bari, Italy.
Christoph ThiemermannWilliam Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.900906.].

Indexed as

aquaporin (AQP)cecal ligation and punctureinflammationmultiple organ failuresepsis

Identifiers

PMID40918091
PMCPMC12409440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.